论文部分内容阅读
你想快速发表吗?你想优惠吗?文章一经录用,费用减半,并优先发表(以投稿日期为准,3个月发表)征文内容涵盖以下方面本期推荐临床学科相关的最新指南或专家共识解读上市新药美国食品药品管理局(FDA)或国家食品药品监督管理局(SFDA)最新批准上市用于临床治疗的各类新药文章类型和要求以综述性论文为主。“上市新药”版块投稿论文可包含以下几方面内容:①药理作用;②临床评价如疗效、用法用量、耐药性;③不良反应;④发展趋势或展望等;⑤以投稿日期前2年内批准上市的新药为准。
Do you want to publish quickly? Do you want to discount it? The articles will be halved and the priority will be published once they are accepted (The submission date is 3 months) The essay covers the following areas: Current guidelines or experts related to recommended clinical subjects Consensus Interpretation of New Drugs The types and requirements of various types of new drug articles approved by the FDA or SFDA for clinical treatment are mainly review papers. “New Drugs listed ” section submission papers can include the following aspects: ① pharmacological effects; ② clinical evaluation such as efficacy, usage and dosage, drug resistance; ③ adverse reactions; ④ development trends or prospects; ⑤ before the submission date 2 The new drugs approved for listing during the year shall prevail.